Loading...

Effect of Ivacaftor on Objective and Subjective Measures of Cough in Patients with Cystic Fibrosis

BACKGROUND AND OBJECTIVES: Cough is a major symptom in cystic fibrosis. Ivacaftor is a novel drug which targets the G551D mutation and has been demonstrated to improve lung function and weight in the long term. It also improves symptoms of extra-oesophageal reflux. We wanted to evaluate the effect o...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Open Respir Med J
Main Authors: Faruqi, Shoaib, Shiferaw, Dejene, Morice, Alyn H.
Format: Artigo
Sprog:Inglês
Udgivet: Bentham Open 2016
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5299558/
https://ncbi.nlm.nih.gov/pubmed/28217196
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1874306401610010105
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!